AKT1 and neoplasm: Recent studies implicated HA-CD44 interaction in tumor cell resistance to chemotherapy, by inducing multi-drug resistance 1 gene (MDR1) expression (62), ABC drug transporters (63), ankyrin-induced drug fluxes (62), and tumor cell survival pathways like ErbB2 signaling and PI3K/AKT pathway (64).